WJOG6510G: Randomized phase II of Pmab + IRI vs Cmab + IRI for KRAS WT mCRC previously treated after FU, IRI, and L-OHP

Hiroki Hara, Daisuke Sakai, Toshimi Takano, Katsunori Shinozaki, Masahiro Goto, Hiroya Taniguchi, Junji Kishimoto, Narikazu Boku, Ichinosuke Hyodo, Kei Muro

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)ix74
    JournalAnnals of oncology : official journal of the European Society for Medical Oncology
    Volume28
    DOIs
    Publication statusPublished - Oct 1 2017

    All Science Journal Classification (ASJC) codes

    • Hematology
    • Oncology

    Cite this